Clinical Trials Directory

Trials / Completed

CompletedNCT05873257

Investigation of the Clinical Performance of Biatain Fiber Ag on Venous Leg Ulcers

Investigation of the Clinical Performance of Biatain Fiber Ag on Venous Leg Ulcer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Coloplast A/S · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this study is to test a new gelling fiber wound dressing with silver on patients with a venous leg ulcer Participants will be asked to wear the test dressing in a four weeks period (+/- 2 days) consisting of 6 study visits, and will have the dressing changed once pr. week at the research facility. The wound will be cleaned, assessed and photos will be uploaded to a digital software system.

Detailed description

: The clinical investigation is a non-comparative, one-armed, open-labelled, multi-centre study The test product, Biatain Fiber Ag is a non-CE-marked gelling fiber wound dressing, containing silver. The product is intended for moist wound healing and exudate management of moderate to high exuding wounds. The overall purpose of this investigation is to obtain clinical data supporting effectiveness of Biatain Fiber Ag to obtain the CE-mark in EU. The total study duration for the subject will be approximately four weeks, consisting of a four-week test period and 6 study visits (V0/V1, V2, V3, V4 and V5). V5 will also terminate the 4-week study period. The primary endpoint is Mean area wound reduction. The endpoint is used to evaluate clinical performance in terms of relative wound area reduction as an indication of total wound healing.

Conditions

Interventions

TypeNameDescription
DEVICEBiatain Fiber Ag applied to participantsIntervention involving a wound gelling fiber dressing with silver

Timeline

Start date
2023-07-31
Primary completion
2024-05-17
Completion
2024-05-17
First posted
2023-05-24
Last updated
2025-06-03
Results posted
2025-06-03

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT05873257. Inclusion in this directory is not an endorsement.